NCT07023302 - A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions

Alopecia Areata

Interventions

DRUG

Upadacitinib

Oral Tablets

DRUG

Upadacitinib Placebo

Oral Tablets

Trial Locations (14)

467-8602

RECRUITING

Nagoya City University Hospital /ID# 275409, Nagoya

830-0011

RECRUITING

Kurume University Hospital /ID# 275519, Kurume-shi

920-0265

RECRUITING

Kanazawa Medical University Hospital /ID# 275521, Kahoku-gun

243-0432

RECRUITING

Nagomi Dermatology Clinic /ID# 275418, Ebina-shi

981-0112

RECRUITING

Rifu Dermatology Allergy Clinic /ID# 274875, Miyagi-gun

951-8520

RECRUITING

Niigata University Medical & Dental Hospital /ID# 274775, Niigata

542-0081

RECRUITING

Shinsaibashi Inui Dermatology Clinic /ID# 274851, Osaka

545-8586

RECRUITING

Osaka Metropolitan University Hospital /ID# 274956, Osaka

431-3192

RECRUITING

Hamamatsu University Hospital /ID# 274639, Hamamatsu

181-8611

RECRUITING

Kyorin University Hospital /ID# 274882, Mitaka-shi

160-0023

RECRUITING

Tokyo Medical University Hospital /ID# 274844, Shinjuku-ku

160-8582

RECRUITING

Keio University Hospital /ID# 275640, Shinjuku-ku

755-8505

RECRUITING

Yamaguchi University Hospital /ID# 274638, Ube

136-0075

RECRUITING

Juntendo Tokyo Koto Geriatric Medical Center /ID# 275424, Tokyo